1-2 of 2
Deqiao Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A78: Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models

Yang Dai, Yichun Ji, Yanyan Shen, Yi Su, Bo Liu, Yueliang Wang, Deqiao Sun, Yuchen Jiang, Chuantao Zha, Zuoquan Xie, Jian Ding, Meiyu Geng, Jing Ai, Xia Peng, Pengcong Hou, Yi Chen
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): A78.
https://doi.org/10.1158/2326-6074.TUMIMM19-A78
Published: 02 March 2020
View article titled, Abstract A78: Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
Journal Articles

Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti–PD-1 Immunotherapy

Wenjie You, Lijun Li, Deqiao Sun, Xueqing Liu, Zongjun Xia, Shan Xue, Bi Chen, Hui Qin, Jing Ai, Handong Jiang
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (6): 990–1000.
https://doi.org/10.1158/2326-6066.CIR-17-0672
Published: 03 June 2019
View article titled, Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR<sup>high</sup>PD-L1<sup>low</sup> NSCLC to Anti–PD-1 Immunotherapy
Open the PDF for Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR<sup>high</sup>PD-L1<sup>low</sup> NSCLC to Anti–PD-1 Immunotherapy in another window
Includes: Supplementary data